From: Induced abortions of women living with HIV in Finland 1987–2019: a national register study
Population | All | Divided by year of HIV diagnosisa | ||||||
---|---|---|---|---|---|---|---|---|
1987–1997 | 1998–2008 | 2009–2019 | ||||||
Number of women | 1017 | 138 | 13.6% | 413 | 40.6% | 466 | 45.8% | |
Median age at HIV diagnosis | 30.7 | 29.0 | 30.4 | 32.0 | ||||
Country of birth | ||||||||
Finland | 428 | 42.1% | 97 | 70.3% | 205 | 49.6% | 126 | 27.0% |
Other | 586 | 57.6% | 41 | 29.7% | 208 | 50.4% | 337 | 72.3% |
Unknown | 3 | 0.3% | 0 | 0 | 3 | 0.6% | ||
Diagnosed before immigration | 159 | 15.6% | 10 | 7.2% | 45 | 10.9% | 104 | 22.3% |
Mode of transmission | ||||||||
Sex | 809 | 79.5% | 118 | 85.5% | 289 | 70.0% | 402 | 86.3% |
IDUb | 99 | 9.7% | 8 | 5.8% | 81 | 19.6% | 10 | 2.1% |
Verticalc | 13 | 1.3% | 3 | 2.2% | 8 | 1.9% | 2 | 0.4% |
Blood transfusionc | 11 | 1.1% | 2 | 1.4% | 2 | 0.5% | 7 | 1.5% |
Unknown | 85 | 8.4% | 7 | 5.1% | 33 | 8.0% | 45 | 9.7% |
Hepatitis C antibodies | ||||||||
Positive | 112 | 11.0% | 6 | 4.3% | 69 | 16.7% | 37 | 7.9% |
Negative | 647 | 63.6% | 87 | 63.0% | 227 | 55.0% | 333 | 71.5% |
Unknown | 258 | 25.4% | 45 | 32.6% | 117 | 28.3% | 96 | 20.6% |
Hepatitis B S-antigen | ||||||||
Positive | 32 | 3.1% | 2 | 1.4% | 14 | 3.4% | 16 | 3.4% |
Negative | 728 | 71.6% | 91 | 65.9% | 282 | 68.3% | 355 | 76.2% |
Unknown | 257 | 25.3% | 45 | 32.6% | 117 | 28.3% | 95 | 20.4% |
CD4+ cell count at diagnosis availabled | 498 | 49.0% | 5 | 3.6% | 203 | 49.2% | 290 | 62.2% |
≥500 | 164 | 32.9% | 1 | 85 | 41.9% | 78 | 26.9% | |
350–499 | 90 | 18.1% | 3 | 39 | 19.2% | 48 | 16.6% | |
200–349 | 110 | 22.1% | 1 | 42 | 20.7% | 67 | 23.1% | |
<200 | 134 | 26.9% | 37 | 18.2% | 97 | 33.4% | ||
AIDSe | 154 | 15.1% | 30 | 21.7% | 61 | 14.8% | 63 | 13.5% |
AIDS within 90 days of HIV | 72 | 7.1% | 3 | 2.2% | 29 | 7.0% | 40 | 8.6% |
Deceased during follow-up | 63 | 6.2% | 18 | 13.0% | 33 | 8.0% | 12 | 2.6% |